MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PTN — Palatin Technologies, Inc. Common Stock
NasdaqPalatin Technologies, Inc. Common Stock
$9.52
+0.11(+1.17%)
- O
- 9.87
- H
- 9.87
- L
- 9.16
- V
- 9.02K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PTN
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 4, 1993
Employees25
Stock ExchangeNasdaq
Ticker SymbolPTN
Websitehttps://www.palatin.com
Key Financial Statistics
| Market Cap | $16.62M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.61 - $31.00 |
| 52-Week Avg Volume | 38.4K |
| VWAP | $9.42 |
| Transactions | 343 |
| Total Recorded Bars | 7,287 days |